The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pooled safety summary for patients treated with the CD22-directed cytotoxin moxetumomab pasudotox-tdfk.
 
Robert J. Kreitman
Research Funding - Genentech (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - MedImmune; MedImmune (Inst)
Travel, Accommodations, Expenses - MedImmune
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; BeiGene; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millenium Pharamceuticals (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; BeiGene; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
 
Cynthia Elesinmogun
Employment - AstraZeneca; AstraZeneca (I)
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I)
 
Nataliya Kuptsova-Clarkson
Employment - AstraZeneca
Stock and Other Ownership Interests - Abbvie; AstraZeneca
 
Xia Li
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ira Pastan
No Relationships to Disclose
 
Douglas Edward Gladstone
Consulting or Advisory Role - AstraZeneca
Research Funding - Gilead Sciences